Medical and Pharmaceutical IceCure Medical takes another step towards a full patent application in US IceCure continues expanding its intellectual property portfolio to strengthen its cryoablation platform Joseph MortonJune 10, 2025
Medical and Pharmaceutical Breath Diagnostics opens Respiratory Innovation Summit with captivating presentation It was an honour for the company to be selected to kick off this prestigious event Rowan DunneJune 9, 2025
Medical and Pharmaceutical Dying woman blames CT scan technicians for cancer spread, files lawsuit Their failure to properly interpret the results will cost her life, she claims Rowan DunneJune 6, 2025
Medical and Pharmaceutical Combining mammograms with lung cancer screening can boost female uptake A recent study from Stanford Medicine made this conclusion Rowan DunneJune 4, 2025
Medical and Pharmaceutical Australia’s first national lung cancer screening program begins in July The aim of the game is to save 12,000 lives by 2035 Rowan DunneJune 3, 2025
Medical and Pharmaceutical DNA blood biopsy to identify personalized treatments for lung cancer patients Thousands in the UK will soon benefit from the state-of-the-art test developed by Guardant Health Rowan DunneMay 30, 2025
Health & Wellness ‘Give a Breath’ 5K run raises lung cancer awareness in Canadian cities next month Ottawa and Calgary are new participants this year Rowan DunneMay 22, 2025
AI and Autonomy Canadian healthcare just got a little more organized with Oracle AI Oracle's agent combines generative AI, agentic technology, automation, multimodal voice, and screen-driven assistance into one solution Joseph MortonMay 15, 2025
Medical and Pharmaceutical International lung cancer screening market poised for steady growth: 2025 report It will be worth over US$1.3 billion more than its current valuation by 2029, The Business Research Company says Rowan DunneMay 9, 2025
Medical and Pharmaceutical Breath Diagnostics now offering a compelling investment opportunity The lung cancer breath test developer is enabling investors to buy US$3 shares through a Reg CF financing Rowan DunneMay 7, 2025